Perspectives on quality, compliance, and innovation to accelerate CGT manufacturing
“...the integration of automation, standardized protocols, evolving regulatory frameworks, and robust scale-up strategies will be critical...” Lauren Coyle, Editor, BioInsights, speaks to Hélène Negre, Pharmaceutical Affairs Director, CELLforCURE, about the manufacturing of ATMPs and how they are undergoing rapid transformations, driven by the need for speed, safety, and scalability. The article shares insights on key challenges in batch release, the importance of cross-functional collaboration, and innovations shaping the future of CGT manufacturing.
Institutions
- LFB (France) (FR)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2025-09-19
- DOI
- https://doi.org/10.18609/cgti.2025.117
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00